Prevalence of serum HGV-RNA among hemodialysis patients in Turkey
✍ Scribed by M. Günaydin; A. Bedir; T. Akpolat; I. Kuku; A. Pekbay; S. Esen; E. Özyilkan; N. Arik; K. Cengiz
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 424 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A high prevalence of anti-Cl00-3 antibodies has been reported in chronic hemodialysis patients. It is, however, unclear whether the results reflect true hepatitis C virus (HCV) infection in these patients, since false-positive results have been reported with this antibody assay. In the present study
In order to study the prevalence of antibody to hepatitis E virus (HEV) among hemodialysis patients and to evaluate whether chronic hemodialysis is associated with an increased risk of exposure to HEV in developed countries, the IgG anti-HEV was determined in serum samples obtained from 182 patients
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested for antibody to HCV by first-and second-generation enzyme immunoassays and for hepatitis C virus RNA by nested polymerase
## Abstract To investigate the prevalence of hepatitis E virus (HEV) infection among patients on maintenance hemodialysis, serum samples collected in January 2003 from 416 patients who had been undergoing hemodialysis for 7.6 ± 6.3 (mean ± standard deviation) (range, 0.3–26.0) years in a dialysis u